AURA Aura Biosciences, Inc.
Price Chart
Executive Summary
Aura Biosciences granted inducement equity awards to new CEO Natalie Holles, consisting of stock options, RSUs, and performance-based RSUs. This is a standard compensation action following her previously disclosed appointment and does not represent a change in business fundamentals.
Actionable Insight
This filing is routine executive compensation. No immediate trading signal. Monitor for clinical data readouts or pipeline updates, which are the primary value drivers for this clinical-stage biotech.
Key Facts
- Inducement awards granted to new CEO Natalie Holles on May 19, 2026.
- Includes options for 2,169,103 shares at $7.39, RSUs for 600,118 shares, and PRSUs for 553,844 shares.
- Awards are consistent with previously disclosed terms of her offer letter approved by the Board.
- No financial results, clinical data, or guidance changes included in the release.
Financial Impact
Undisclosed; inducement awards are standard compensation and do not represent cash outlay.
Risk Factors
- Potential dilution from equity awards if vested and exercised.
- No change in fundamental risks related to clinical development or regulatory approval.
Market Snapshot
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3297997 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
May 19, 2026
4d ago
|
Press Release
| — | awaiting T+5 | — | — |
|
May 5, 2026
18d ago
|
8-K
| $8.29 $7.93 | ▲ +4.34% | ▲ +5.47% | $7.60 (+8.32%) |
|
May 5, 2026
18d ago
|
Press Release
| $8.29 $7.93 | ▲ +4.34% | ▲ +5.47% | $7.60 (+8.32%) |
|
May 4, 2026
19d ago
|
8-K
| $8.90 $7.93 | ▼ −10.90% | ▼ −12.88% | $7.60 (−14.61%) |
|
May 4, 2026
19d ago
|
Press Release
| $8.35 $8.19 | ▲ +1.92% | ▲ +4.85% | $7.60 (+8.98%) |
|
May 4, 2026
19d ago
|
424B5
| $8.35 $8.19 | ▲ +1.92% | ▲ +4.85% | $7.60 (+8.98%) |
|
May 4, 2026
19d ago
|
8-K
| $8.35 $8.19 | ▼ −1.92% | ▼ −4.85% | $7.60 (−8.98%) |
|
May 4, 2026
19d ago
|
Press Release
| $8.35 $8.19 | ▲ +1.92% | ▲ +4.85% | $7.60 (+8.98%) |
|
May 4, 2026
19d ago
|
Press Release
| $8.35 $8.19 | ▼ −1.92% | ▼ −4.85% | $7.60 (−8.98%) |
|
Apr 20, 2026
4w ago
|
DEFA14A
| $7.44 $6.96 | ▼ −6.45% | ▼ −7.54% | $7.60 (+2.15%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access